HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease.

Abstract
Dopamine agonists used to manage Parkinsonian motor symptoms have been suggested to be neuroprotective. The study was designed to assess the neuroprotective potential of the D(3)/D(2)/D(1) dopamine receptor agonist rotigotine in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned (MPTP) mouse model of Parkinson's disease by measuring mesencephalic degenerating neurons using FluoroJade staining and the remaining dopaminergic nerve endings in the striatum using dopamine transporter binding. Continuous administration of rotigotine at a dose of 3mg/kg significantly attenuated MPTP-induced acute cell degeneration in the FluoroJade-staining paradigm. Rotigotine (0.3-3mg/kg) partially protected dopamine nerve endings from MPTP-induced degeneration in a dose-dependent manner. These data suggest that rotigotine, at the doses employed, significantly protected dopamine neurons from degeneration in an acute mouse model of MPTP intoxication.
AuthorsDieter Scheller, Christine Stichel-Gunkel, Hermann Lübbert, Gregory Porras, Paula Ravenscroft, Michael Hill, Erwan Bezard
JournalNeuroscience letters (Neurosci Lett) Vol. 432 Issue 1 Pg. 30-4 (Feb 13 2008) ISSN: 0304-3940 [Print] Ireland
PMID18162314 (Publication Type: Journal Article)
Chemical References
  • Dopamine Agonists
  • Iodine Radioisotopes
  • Neuroprotective Agents
  • Receptors, Dopamine
  • Tetrahydronaphthalenes
  • Thiophenes
  • rotigotine
Topics
  • Acute Disease
  • Administration, Cutaneous
  • Animals
  • Corpus Striatum (drug effects, metabolism)
  • Dopamine Agonists (pharmacology)
  • Dose-Response Relationship, Drug
  • Iodine Radioisotopes
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nerve Degeneration (drug therapy, prevention & control)
  • Neuroprotective Agents (pharmacology)
  • Parkinsonian Disorders (drug therapy, prevention & control)
  • Radioligand Assay
  • Receptors, Dopamine (metabolism)
  • Substantia Nigra (drug effects, metabolism)
  • Tetrahydronaphthalenes (pharmacology)
  • Thiophenes (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: